# Study of the Effects of Cyclodynon on Reducing the Cumulative Risk of Breast Cancer Development in a Female Aged 40-52

> **NCT04498013** · PHASE4 · UNKNOWN · sponsor: **Dr. Struk Tetiana** · enrollment: 150 (estimated)

## Conditions studied

- Mammographic Breast Density

## Interventions

- **DRUG:** Cyclodynon
- **BEHAVIORAL:** Lifestyl modification

## Key facts

- **NCT ID:** NCT04498013
- **Lead sponsor:** Dr. Struk Tetiana
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-22
- **Primary completion:** 2022-04-01
- **Final completion:** 2022-05-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2020-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04498013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04498013, "Study of the Effects of Cyclodynon on Reducing the Cumulative Risk of Breast Cancer Development in a Female Aged 40-52". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04498013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*